LEADER 01325nam a2200289 u 4500
001 EB000942638
003 EBX01000000000000000736228
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
050 4 |a RC150 
100 1 |a La Montagne, John 
245 0 0 |a John R. La Montagne Memorial Symposium on Pandemic Influenza Research  |h Elektronische Ressource  |b meeting proceedings  |c Board on Population Health and Public Health Practice, Institute of Medicine 
260 |a Washington, D.C.  |b National Academies Press  |c 2005, 2005 
300 |a x, 204 p.  |b ill 
653 |a Disease Outbreaks / prevention & control 
653 |a Influenza Vaccines 
653 |a Influenza, Human / prevention & control 
710 2 |a John R. La Montagne Memorial Symposium on Pandemic Influenza Research (2005, Institute of Medicine) 
710 2 |a National Academies Press (U.S.) 
710 2 |a Institute of Medicine (U.S.)  |b Board on Population Health and Public Health Practice 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
856 4 0 |u http://www.nap.edu/catalog.php?record_id=11448  |3 Volltext  |n Provider site  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK25576  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 140 
082 0 |a 610